Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Preferred Shares Repurchased (2020)

Vivos Therapeutics' Preferred Shares Repurchased history spans 1 years, with the latest figure at $2.0 million for Q4 2020.

  • Quarterly results put Preferred Shares Repurchased at $2.0 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2021 was $2.0 million (down 6.98% YoY), and the annual figure for FY2021 was $1.5 million, down 30.23%.
  • Preferred Shares Repurchased for Q4 2020 was $2.0 million at Vivos Therapeutics, up from $150000.0 in the prior quarter.
  • In the past five years, Preferred Shares Repurchased ranged from a high of $2.0 million in Q4 2020 to a low of $150000.0 in Q1 2020.